Brilliant innovations revealed at SEMDA conference
Atlanta is emerging as a healthcare Silicon Valley – with more evidence at the Southeast Medical Device Association (SEMDA) conference in May.
Imagine it – 20 companies, all with their own intriguing medical device, delivering their pitch to angel investors in the audience. These were the “best of the best” selected from a long list of entrants. Brilliant minds behind every single invention.
Among my favorites: Admetsys, a device for hospitals to use in monitoring glucose control in patients. Here’s a video link to learn more: http://admetsys.com/about/intro/
Jeff Valk who led the device’s development, says: “SEMDA opened doors to financing, and also some potential ones for scaling up our clinical research. Our SEMDA conference experience was extremely positive. The sense of community, purpose, and building momentum is a powerful combination.”
Equally intriguing:
Arkis Biosciences – exciting new medical tools and implants to bring treatment of hydrocephalus into the 21st century. Very promising developments for a serious condition that has been overlooked by medical research.
Clean Hands Safe Hands – a cost-effective, non-intrusive, wireless technology designed to help hospitals remind providers to use the hand sanitizer and monitor compliance. The device can sense a human presence in the room, and has a “voice” that actually reprimands the human who has not used the hand sanitizer.
Better Walk Inc. – a new type of crutch that improves the experience of a crutch user, virtually eliminating under-arm pain.
Sensiotec, Inc. – the “Virtual Assistant,” the world’s first non-contact patient monitor. It uses a FDA-cleared radar sensor panel to provide cardiorespiratory, patient motion, and bed presence monitoring without the use of electrodes or wires. The sensor panel is simply placed under a patient’s bed to start continuously measuring and displaying critical vital signs.
Vigilant Biosciences – a low-cost, non-invasive screening test for oral cancer – so that the cancer is detectable at a much earlier stage, to avoid disfiguring treatments.
If you can imagine a medical version of “Shark Tank,” you’ve got a clear idea of the annual SEMDA conference.
At Write2Health, we help healthcare tech companies set their brands apart in the crowded marketplace. We help you tell your story–in case studies, blogs, web content and more. To contact us, simply email jeaniedavis1@gmail.com.